Investisseurs
39
Installations
> 2.2 MILLION
pieds carrés de capacité
PLUS DE 200 ANS
Expérience dans l’industrie de la haute direction
Andlauer Healthcare Group (AND)
Investir dans Andlauer
Groupe Santé Andlauer est le principal prestataire de services essentiels de chaîne d’approvisionnement dans le domaine médical. Nous fournissons des solutions spécialisées de façon à satisfaire aux exigences extrêmement réglementées et rigoureuses du secteur médical. Forts d’un réseau national d’une capacité plus de deux millions de pieds carrés, d’une équipe à la fois passionnée et expérimentée et de dispositifs de sécurité de pointe, nous garantissons une prestation de services sécurisée et efficace à nos clients. C’est pourquoi nous sommes le partenaire de choix des 25 principaux fabricants pharmaceutiques internationaux au Canada.
Documents réglementaires, rapports et présentations
Documents SEDAR
Rapport financier
Télécharger
Notice Annuelle
Télécharger
Circulaire d'information de la direction
Télécharger
Rapport annuel
Télécharger
Présentation actuelle
Renseignements sur les dividendes
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Record Date
Payment Date
Dividend (per share)
MONTH XX
20XX MONTH XX
$X.XX
MONTH XX
20XX MONTH XX
$X.XX
MONTH XX
20XX MONTH XX
$X.XX
FAQ sur les investisseurs
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.
Special Shareholder Meeting Information
Andlauer Healthcare Group is holding a special meeting of shareholders on Tuesday, June 24, 2025 at 11:00 am (Toronto time) (the “Meeting”) for shareholders to consider and vote on a special resolution (the “Arrangement Resolution”) approving a plan of arrangement pursuant to which affiliates of UPS (NYSE: UPS) will acquire all of the issued and outstanding shares of Andlauer Healthcare Group for C$55.00 per share in cash, as more fully described in the management information circular dated May 20, 2025 (the “Information Circular”). The Arrangement Resolution requires approval of at least two-thirds of the votes cast by shareholders at the Meeting, voting together as a single class.
Please find below the Information Circular, letter of transmittal and form of proxy related to the Meeting.
To access the link for the Meeting on June 24, 2025, click here: https://andlauerhealthcare.com/andlauer-healthcare-presentations-events/
In light of the potential Canada Post labour disruption, shareholders may experience delays in receiving physical copies of the Information Circular and related materials for the meeting (the “Meeting Materials”). This potential delay only applies to Canadian shareholders as of the record date for the Meeting who have previously requested that physical copies of the Meeting Materials be sent to them. If you are a Canadian beneficial shareholder (i.e., you hold your shares with one or more financial institutions or brokers), and you do not receive a voting instruction form with your control number, you are encouraged to contact your brokerage firm, financial institution or other intermediary and request the control number for each of your accounts that hold shares. Once you have obtained your control number(s), you can vote the shares represented by such control number(s) at www.proxyvote.com.
As a result of the potential Canada Post labour disruption, proxies and voting instruction forms that shareholders mail back to Broadridge Investor Communications Corporation (“Broadridge”) in Canada may not be received by Broadridge prior to the proxy deadline set out in the Information Circular. Accordingly, all shareholders are strongly encouraged to vote their shares online or by telephone as instructed in the Meeting Materials. It is recommended that any physical forms of proxy or voting instruction forms be delivered via hand or courier (other than Canada Post) to ensure that they are received in a timely manner. Shareholders should contact Broadridge by email at proxy.request@broadridge.com if they need any assistance in voting their shares.